
कृपया अन्य खोज का प्रयास करें
चिन्ह | एक्सचेंज | करेंसी | ||
---|---|---|---|---|
INDV | लंदन | GBP | रियल टाइम | |
INDVl | BATS Europe | GBP | देरी | |
INDV | NASDAQ | USD | रियल टाइम | |
2IVB | फ़्रंकफ़र्ट | EUR | देरी | |
2IVB | ट्रेडगेट | EUR | देरी |
Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. The company develops medicines to treat substance use disorders. Its core marketed products include SUBLOCADE buprenorphine extended-release monthly injections; SUBOXONE Film, a buprenorphine and naloxone sublingual film; SUBOXONE Tablet, a buprenorphine and naloxone sublingual tablet; and SUBUTEX Tablet, a buprenorphine sublingual tablet for the treatment of opioid use disorder (OUD). The company also offers OPVEE nasal spray for opioid overdose reversal. In addition, it is developing INDV-2000, a selective orexin-1 receptor antagonist that is in Phase 2 clinical trial for the treatment of moderate to severe OUD; and INDV-6001, a buprenorphine-based long-acting injectable for the treatment of OUD in collaboration with Alar Pharmaceuticals Inc. Indivior PLC was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Mark Crossley | - | 2014 | CEO & Executive Director |
Joanna Susan Le Couilliard | 62 | 2021 | Independent Non-Executive Director |
Mark P. Stejbach | 62 | 2021 | Independent Non-Executive Director |
David E. Wheadon | 66 | 2024 | Independent Non-Executive Chairman |
Juliet Thompson | 59 | 2021 | Lead Independent Director |
Peter James Jonathan Bains | 68 | 2019 | Independent Non-Executive Director |
Barbara A. Ryan | 65 | 2022 | Independent Non-Executive Director |
Daniel A. Ninivaggi | 60 | 2025 | Independent Non-Executive Director |
Keith Humphreys | 58 | 2023 | Independent Non-Executive Director |
Joseph J. Ciaffoni | 53 | 2024 | Independent Non-Executive Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है